NASDAQ:BIOSU

BioPlus Acquisition - BIOSU Stock Forecast, Price & News

$9.99

0.00 (0.00%)

(As of 08/10/2022 12:00 AM ET)

Add

Compare

Today's Range: $9.99
▼
$9.99
50-Day Range: $9.97
▼
$10.06
52-Week Range: $9.92
▼
$10.07

Volume: N/A
Average Volume: 18,602 shs
Market Capitalization: N/A

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

About BioPlus Acquisition (NASDAQ:BIOSU) Stock

BioPlus Acquisition Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or other similar business combination with one or more businesses in the life sciences industry. The company was incorporated in 2021 and is based in New York, New York.

BioPlus Acquisition Price Performance

NASDAQ:BIOSU opened at $9.99 on Thursday. The stock has a 50 day moving average of $10.02 and a 200-day moving average of $10.00. BioPlus Acquisition has a 52 week low of $9.92 and a 52 week high of $10.07.

Receive BIOSU Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for BioPlus Acquisition and its competitors with MarketBeat's FREE daily newsletter.

BIOSU Stock News Headlines

February 3, 2022 | nasdaq.com

BioPlus Acquisition Corp. Unit (BIOSU)

January 31, 2022 | finance.yahoo.com

BioPlus Acquisition Corp. Announces Pricing of Upsized $200,000,000 Initial Public Offering

See More Headlines

30 days | 90 days | 365 days | Advanced Chart

Receive BIOSU Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for BioPlus Acquisition and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: - -
Sub-Industry: N/A
Sector: Finance
Current Symbol: NASDAQ:BIOSU
CUSIP: N/A
CIK: 1856653
Web: bioplusspac.com
Phone: 212 287 4092
Fax: N/A
Employees: N/A
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: N/A
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: N/A
Quick Ratio: N/A

Sales & Book Value

Annual Sales: N/A
Price / Sales: N/A
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: N/A
Price / Book: N/A

Miscellaneous

Outstanding Shares: N/A
Free Float: N/A
Market Cap: N/A
Optionable: Not Optionable
Beta: N/A

Key Executives

Mr. Jonathan M. N. Rigby MBA (Age 54)
Chairman & Chief Bus. Officer
Mr. Ross Haghighat (Age 58)
CEO, CFO & Director

Key Competitors

View All Competitors

Insiders & Institutions

View All Insider Transactions
View All Institutional Transactions

BIOSU Stock - Frequently Asked Questions

How have BIOSU shares performed in 2022?: BioPlus Acquisition's stock was trading at $10.00 at the start of the year. Since then, BIOSU shares have decreased by 0.1% and is now trading at $9.99.
View the best growth stocks for 2022 here.
When did BioPlus Acquisition IPO?: (BIOSU) raised $200 million in an IPO on Friday, December 3rd 2021. The company issued 20,000,000 shares at $10.00 per share.

What is BioPlus Acquisition's stock symbol?: BioPlus Acquisition trades on the NASDAQ under the ticker symbol "BIOSU."
Who are BioPlus Acquisition's major shareholders?: BioPlus Acquisition's stock is owned by many different retail and institutional investors. Top institutional investors include Wealthspring Capital LLC (0.00%), Sage Mountain Advisors LLC (0.00%), Wolverine Asset Management LLC (0.00%) and Robinson Capital Management LLC (0.00%).
How do I buy shares of BioPlus Acquisition?: Shares of BIOSU stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.
What is BioPlus Acquisition's stock price today?: One share of BIOSU stock can currently be purchased for approximately $9.99.
How can I contact BioPlus Acquisition?: The official website for the company is bioplusspac.com. The company can be reached via phone at 212 287 4092.

This page (NASDAQ:BIOSU) was last updated on 8/11/2022 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

MarketBeat Resources